This is our Friday rubric: every week a new Science Page from the Bob Morrison’s Swine Health Monitoring Project. The previous editions of the science page are available on our website.
Dr. Iseki and colleagues from the National Institute of Animal Health (NIAH, Japan) present studies on heterologous protection between Japanese type 1 and type 2 porcine reproductive and respiratory syndrome virus (PRRSV) isolates. The level of cross-protection that a type 2-based PRRSV vaccine can confer against various type 1 PRRSV field strains is important because no type 1 PRRSV-based vaccine is commercially available in Japan. Find this work here as an advanced publication of the Journal of Veterinary Medical Science.
Key Points:
- This study evaluated the cross-protective immunity between type 1 and type 2 PRRSV isolates in growing pigs.
- Immunity induced by the type 1 infection may play a role in reducing viremia caused by the type 2 PRRSV.
- The immunity induced by the type 2 may not contribute to cross-protection against the type 1.
A comparison from a prevalence standpoint between the cohort of farms belonging to the 13 systems participating at the start of the MSHMP (CS) and the cohort of farms from systems that joined the program later (CL), was performed with the objective of assessing whether the patterns between cohorts compare.